Comparison of dose volume parameters evaluated using three forward planning - optimization techniques in cervical cancer brachytherapy involving two applicators

被引:10
|
作者
Chakrobarti, Bikramjit [1 ,2 ]
Basu-Roy, Somapriya
Kar, Sanjay Kumar
Das, Sounik
Lahiri, Annesha
机构
[1] Inst Postgrad Med Educ & Res, Dept Radiotherapy, Kolkata 700020, India
[2] Seth Sukhlal Kernani Mem Hosp, Kolkata 700020, India
关键词
cervical cancer; cervix; carcinoma; dosimetry; optimization; INTRACAVITARY BRACHYTHERAPY; AMERICAN BRACHYTHERAPY; COMPUTED-TOMOGRAPHY; MRI; RECOMMENDATIONS; BLADDER; GUIDELINES; CARCINOMA; ANATOMY; TANDEM;
D O I
10.5114/jcb.2017.70677
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This study is intended to compare dose-volume parameters evaluated using different forward planning optimization techniques, involving two applicator systems in intracavitary brachytherapy for cervical cancer. It looks for the best applicator-optimization combination to fulfill recommended dose-volume objectives in different high-dose rate (HDR) fractionation schedules. Material and methods: We used tandem-ring and Fletcher-style tandem-ovoid applicator in same patients in two fractions of brachytherapy. Six plans were generated for each patient utilizing 3 forward optimization techniques for each applicator used: equal dwell weight/times ('no optimization'), 'manual dwell weight/times', and 'graphical'. Plans were normalized to left point A and dose of 8 Gy was prescribed. Dose volume and dose point parameters were compared. Results: Without graphical optimization, maximum width and thickness of volume enclosed by 100% isodose line, dose to 90%, and 100% of clinical target volume (CTV); minimum, maximum, median, and average dose to both rectum and bladder are significantly higher with Fletcher applicator. Even if it is done, dose to both points B, minimum dose to CTV, and treatment time; dose to 2 cc (D-2cc) rectum and rectal point etc.; D-2cc, minimum, maximum, median, and average dose to sigmoid colon; D-2cc of bladder remain significantly higher with this applicator. Dose to bladder point is similar (p > 0.05) between two applicators, after all optimization techniques. Conclusions: Fletcher applicator generates higher dose to both CTV and organs at risk (2 cc volumes) after all optimization techniques. Dose restriction to rectum is possible using graphical optimization only during selected HDR fractionation schedules. Bladder always receives dose higher than recommended, and 2 cc sigmoid colon always gets permissible dose. Contrarily, graphical optimization with ring applicators fulfills all dose volume objectives in all HDR fractionations practiced.
引用
收藏
页码:431 / 445
页数:15
相关论文
共 50 条
  • [31] Interaction between the Number of Chemotherapy Cycles and Brachytherapy Dose/Volume Parameters in Locally Advanced Cervical Cancer Patients
    Escande, Alexandre
    Khettab, Mohamed
    Bockel, Sophie
    Dumas, Isabelle
    Schernberg, Antoine
    Gouy, Sebastien
    Morice, Philippe
    Pautier, Patricia
    Deutsch, Eric
    Haie-Meder, Christine
    Chargari, Cyrus
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06)
  • [32] CT based three dimensional dose-volume evaluations for high-dose rate intracavitary brachytherapy for cervical cancer
    Murakami, Naoya
    Kasamatsu, Takahiro
    Wakita, Akihisa
    Nakamura, Satoshi
    Okamoto, Hiroyoki
    Inaba, Koji
    Morota, Madoka
    Ito, Yoshinori
    Sumi, Minako
    Itami, Jun
    BMC CANCER, 2014, 14
  • [33] Comparative Evaluation of Two-dimensional Radiography and Three Dimensional Computed Tomography Based Dose-volume Parameters for High-dose-rate Intracavitary Brachytherapy of Cervical Cancer: A Prospective Study
    Madan, Renu
    Pathy, Sushmita
    Subramani, Vellaiyan
    Sharma, Seema
    Mohanti, Bidhu Kalyan
    Chander, Subhash
    Thulkar, Sanjay
    Kumar, Lalit
    Dadhwal, Vatsla
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (11) : 4717 - 4721
  • [34] Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer
    Annede, Pierre
    Dumas, Isabelle
    Schernberg, Antoine
    Tailleur, Anne
    Fumagalli, Ingrid
    Bockel, Sophie
    Mignot, Fabien
    Kissel, Manon
    Deutsch, Eric
    Haie-meder, Christine
    Chargari, Cyrus
    BRACHYTHERAPY, 2019, 18 (03) : 370 - 377
  • [35] DOSE-VOLUME HISTOGRAM PARAMETERS AND LATE SIDE EFFECTS IN MAGNETIC RESONANCE IMAGE-GUIDED ADAPTIVE CERVICAL CANCER BRACHYTHERAPY
    Georg, Petra
    Lang, Stefan
    Dimopoulos, Johannes C. A.
    Doerr, Wolfgang
    Sturdza, Alina E.
    Berger, Daniel
    Georg, Dietmar
    Kirisits, Christian
    Poetter, Richard
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (02): : 356 - 362
  • [36] Comparison of dosimetric parameters in the treatment planning of magnetic resonance imaging-based intracavitary image-guided adaptive brachytherapy with and without optimization using the central shielding technique
    Nishikawa, Ryo
    Yoshida, Kenji
    Ebina, Yasuhiko
    Omoteda, Mayumi
    Miyawaki, Daisuke
    Ishihara, Takeaki
    Ejima, Yasuo
    Akasaka, Hiroaki
    Satoh, Hitoaki
    Kyotani, Katsusuke
    Takahashi, Satoru
    Sasaki, Ryohei
    JOURNAL OF RADIATION RESEARCH, 2018, 59 (03) : 316 - 326
  • [37] Dosimetric comparison of AcurosBV with AAPM TG43 dose calculation formalism in cervical intraductal high-dose-rate brachytherapy using three different applicators
    Bi, Su-yan
    Chen, Zhi-jian
    Sun, Xing-ru
    Dai, Zhi-tao
    PRECISION RADIATION ONCOLOGY, 2022, 6 (03): : 234 - 242
  • [38] Comparison of two high dose rate intracavitary brachytherapy regimens in treatment of cervical cancer: a preliminary report
    Krishna, Abhishek
    Hasib, A. G.
    Fernandes, Donald
    Athiyamaan, M. S.
    Rao, Sandesh
    Shankar, Sharaschandra
    Ali, Mohsina
    Priyadarshini, Hepsiba
    Sophia, Maria
    Shridhar, C. H.
    George, Seby
    Babu, Amrutha
    Banerjee, Sourjya
    Sunny, Johan
    Srinivas, Challapalli
    Lobo, Dilson
    DISCOVER ONCOLOGY, 2023, 14 (01)
  • [39] Dose evaluation of organs at risk (OAR) cervical cancer using dose volume histogram (DVH) on brachytherapy
    Wibowo, R. Arif
    Haris, Bambang
    Islamiyah, Inganatul
    INTERNATIONAL CONFERENCE ON PHYSICAL INSTRUMENTATION AND ADVANCED MATERIALS, 2017, 853
  • [40] LATE EFFECTS AFTER RADIOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER: COMPARISON OF TWO BRACHYTHERAPY SCHEDULES AND EFFECT OF DOSE DELIVERED WEEKLY
    Hellebust, Taran Paulsen
    Kristensen, Gunnar B.
    Olsen, Dag Rune
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (03): : 713 - 718